From: UA News
Tucson-based Cancer Prevention Pharmaceuticals, Inc. has helped launch a Phase III clinical trial to test the efficacy of a combination drug that has shown promise of preventing colon cancer. The company was founded by a University of Arizona professor emeritus and former UA researcher. The trial is funded by the National Cancer Institute.
Read More: